Where is Numab headquartered?

Numab is located in Wadenswil, zurich.

Who invested in Numab?

Numab has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Numab?

Numab closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

numab.com

Numab

Numab is a Switzerland-based biopharmaceutical company that develops and commercializes immuno-oncology therapies for the treatment of cancer.

Business Model:

Revenue: $52.2M

Employees: 11-50

Geographic Data

Address: Einsiedlerstrasse 34

City: Wadenswil

State: zurich

Zip: CH-8820

Country: CH

Financial Info

Stage:

series c

Raised Last:

$111M

Raised Total:

$133M

Social

Twitter

Crunchbase

Metrics

6,545,770Website Global Rank

827Website Monthly Traffic

Twitter Followers

Description

Numab is a Switzerland-based biopharmaceutical company that develops and commercializes immuno-oncology therapies for the treatment of cancer.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised
12/2019	3sbio	Post-IPO Equity	15.2M
12/2019	3sbio	Post-IPO Equity	0

Startup Demographics

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2022	Series C	1	-	HBM Healthcare Investments AG HBM Healthcare Investments AG
3/2020	Series B		$23.8M	Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd Mitsubishi UFJ Capital Co., Ltd Eisai Co., Ltd
5/2021	Series C	9	$110.6M	BlackRock BVF Partners Cormorant Asset Management Forbion Capital Partners HBM Healthcare Investments AG HBM Partners Novo Holdings Octagon Capital Advisors RTW Investments BlackRock BVF Partners Cormorant Asset Management Forbion Capital Partners HBM Healthcare Investments AG HBM Partners Novo Holdings Octagon Capital Advisors RTW Investments
12/2019	Series B	3	$22.3M	3sbio Eisai Mitsubishi UFJ Capital 3sbio Eisai Mitsubishi UFJ Capital
12/2019	Series B		$15.2M	Sansheng Guojian Pharmaceutical (Shanghai) Co., Ltd
5/2021	Series C		$110M	Novo Holdings HBM Partners Forbion Growth Opportunities Fund BVF Partners L.P. RTW Investments L.P.
5/2021	Series C	9	$110.6M	BlackRock BVF Partners Cormorant Asset Management Forbion Capital Partners HBM Healthcare Investments AG HBM Partners Novo Holdings Octagon Capital Advisors RTW Investments LLC BlackRock BVF Partners Cormorant Asset Management Forbion Capital Partners HBM Healthcare Investments AG HBM Partners Novo Holdings Octagon Capital Advisors RTW Investments LLC
12/2019	Series B	3	$22.3M	3sbio 3sbio

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details